GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PeptiDream Inc (TSE:4587) » Definitions » Loans Receivable

PeptiDream (TSE:4587) Loans Receivable : 円0 Mil (As of Dec. 2024)


View and export this data going back to 2013. Start your Free Trial

What is PeptiDream Loans Receivable?

PeptiDream's Loans Receivable for the quarter that ended in Dec. 2024 was 円0 Mil.


PeptiDream Loans Receivable Historical Data

The historical data trend for PeptiDream's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PeptiDream Loans Receivable Chart

PeptiDream Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Dec20 Dec21 Dec22 Dec23 Dec24
Loans Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

PeptiDream Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

PeptiDream Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


PeptiDream Loans Receivable Related Terms

Thank you for viewing the detailed overview of PeptiDream's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


PeptiDream Business Description

Traded in Other Exchanges
N/A
Address
1-2-10, Nihonbashi, Chuo-ku, Toyo Building, 6th Floor, Tokyo, JPN, 103-0027
PeptiDream Inc is a biopharmaceutical company, engaged in the research and development of new pharmaceutical candidates. It discovers constrained peptides, small molecules, and peptide-drug conjugate therapeutics using its Peptide Discovery Platform System. The company aspires to be a leader in drug discovery and development to address unmet medical needs and improve the quality of life of patients worldwide.

PeptiDream Headlines

No Headlines